Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1993 May;69(5):373–375. doi: 10.1136/hrt.69.5.373

Angiotensin converting enzyme inhibitors in heart failure: how good are they?

J N Townend 1, W A Littler 1
PMCID: PMC1025093  PMID: 8518054

Full text

PDF
373

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anand I. S., Kalra G. S., Ferrari R., Wahi P. L., Harris P. C., Poole-Wilson P. A. Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. Int J Cardiol. 1990 Sep;28(3):341–346. doi: 10.1016/0167-5273(90)90317-x. [DOI] [PubMed] [Google Scholar]
  2. Anand I. S., Kalra G. S., Ferrari R., Wahi P. L., Harris P. C., Poole-Wilson P. A. Enalapril as initial and sole treatment in severe chronic heart failure with sodium retention. Int J Cardiol. 1990 Sep;28(3):341–346. doi: 10.1016/0167-5273(90)90317-x. [DOI] [PubMed] [Google Scholar]
  3. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen-Solal A., Zannad F., Kayanakis J. G., Gueret P., Aupetit J. F., Kolsky H. Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of the exercise protocol. The VO2 French Study Group. Eur Heart J. 1991 Oct;12(10):1055–1063. doi: 10.1093/oxfordjournals.eurheartj.a059837. [DOI] [PubMed] [Google Scholar]
  7. Cohen-Solal A., Zannad F., Kayanakis J. G., Gueret P., Aupetit J. F., Kolsky H. Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Comparison of graphical methods, interobserver variability and influence of the exercise protocol. The VO2 French Study Group. Eur Heart J. 1991 Oct;12(10):1055–1063. doi: 10.1093/oxfordjournals.eurheartj.a059837. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  9. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  10. Colucci W. S., Alexander R. W., Williams G. H., Rude R. E., Holman B. L., Konstam M. A., Wynne J., Mudge G. H., Jr, Braunwald E. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med. 1981 Jul 23;305(4):185–190. doi: 10.1056/NEJM198107233050402. [DOI] [PubMed] [Google Scholar]
  11. Daffos F., Forestier F., Grangeot-Keros L., Capella Pavlovsky M., Lebon P., Chartier M., Pillot J. Prenatal diagnosis of congenital rubella. Lancet. 1984 Jul 7;2(8393):1–3. doi: 10.1016/s0140-6736(84)91993-7. [DOI] [PubMed] [Google Scholar]
  12. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med. 1991 Aug 1;325(5):293–302. doi: 10.1056/NEJM199108013250501. [DOI] [PubMed] [Google Scholar]
  13. Franciosa J. A., Weber K. T., Levine T. B., Kinasewitz G. T., Janicki J. S., West J., Henis M. M., Cohn J. N. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J. 1982 Sep;104(3):587–594. doi: 10.1016/0002-8703(82)90231-9. [DOI] [PubMed] [Google Scholar]
  14. Franciosa J. A., Wilen M. M., Jordan R. A. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. J Am Coll Cardiol. 1985 Jan;5(1):101–107. doi: 10.1016/s0735-1097(85)80090-5. [DOI] [PubMed] [Google Scholar]
  15. Kramer B. L., Massie B. M., Topic N. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation. 1983 Apr;67(4):807–816. doi: 10.1161/01.cir.67.4.807. [DOI] [PubMed] [Google Scholar]
  16. Kriett J. M., Kaye M. P. The Registry of the International Society for Heart Transplantation: seventh official report--1990. J Heart Transplant. 1990 Jul-Aug;9(4):323–330. [PubMed] [Google Scholar]
  17. Likoff M. J., Chandler S. L., Kay H. R. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol. 1987 Mar 1;59(6):634–638. doi: 10.1016/0002-9149(87)91183-0. [DOI] [PubMed] [Google Scholar]
  18. McGrath B. P., Arnolda L., Matthews P. G., Jackson B., Jennings G., Kiat H., Johnston C. I. Controlled trial of enalapril in congestive cardiac failure. Br Heart J. 1985 Oct;54(4):405–414. doi: 10.1136/hrt.54.4.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  20. Riegger G. A. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. Eur Heart J. 1991 Jun;12(6):705–711. doi: 10.1093/eurheartj/12.6.705. [DOI] [PubMed] [Google Scholar]
  21. Riegger G. A. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure. Eur Heart J. 1991 Jun;12(6):705–711. doi: 10.1093/eurheartj/12.6.705. [DOI] [PubMed] [Google Scholar]
  22. Sharpe D. N., Murphy J., Coxon R., Hannan S. F. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Circulation. 1984 Aug;70(2):271–278. doi: 10.1161/01.cir.70.2.271. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES